Document Detail


Terodiline treatment of detrusor hyperreflexia in sclerosis multiplex.
MedLine Citation:
PMID:  2674379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A single-blind placebo controlled study on the efficacy of the anticholinergic and calcium blocking agent terodiline (Mictrol) on detrusor hyperreflexia has been done in 10 patients with multiple sclerosis in a stable state. The patients were evaluated by means of micturition charts, uroflowmetry and cystourethrometry, including electromyography of the periurethral sphincter in females and the bulbocavernosus muscle in males. After 6 weeks on terodiline 25 mg twice a day, the volume per voluntary micturition increased 23 per cent. The number of incontinence episodes decreased. Bladder volume at first urge increased 55 per cent, the maximum cystometric capacity increased 52 per cent, and the detrusor pressure of the first involuntary contraction decreased 27 per cent. The number of voluntary micturitions and voided volume per 24-hour, maximum and average flow, residual urine and urethral pressure at first urge remained unaltered. Terodiline is an alternative drug in the treatment of detrusor hyperreflexia. A follow-up investigation indicates that an increase in terodiline dosage may improve the results.
Authors:
D Jensen
Related Documents :
1690479 - Effects of an alpha 1-adrenergic blocker (prazosin hcl) on micturition disturbances ass...
3294729 - Principles of modern urodynamic studies.
9806179 - Pressure-flow studies before and after transurethral microwave thermotherapy of benign ...
10081949 - Urethral pressure response to cough and voluntary perineal contraction in men without p...
961889 - Time course of ureteral changes with obstruction.
18760159 - Urodynamic responses to anal stretch in patients with detrusor sphincter dyssynergia.
15466569 - Synchronous effects of temperature, hydrostatic pressure, and salinity on growth, phosp...
10466469 - Changes in short-term variability of blood pressure and heart rate during the developme...
14769599 - Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of the Oslo city hospitals     Volume:  39     ISSN:  0030-6207     ISO Abbreviation:  J Oslo City Hosp     Publication Date:    1989 Jun-Jul
Date Detail:
Created Date:  1989-10-18     Completed Date:  1989-10-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7908151     Medline TA:  J Oslo City Hosp     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  67-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Butylamines / therapeutic use*
Calcium Channel Blockers / therapeutic use*
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Multiple Sclerosis / complications*
Urinary Bladder, Neurogenic / drug therapy*,  etiology
Chemical
Reg. No./Substance:
0/Butylamines; 0/Calcium Channel Blockers; 15793-40-5/terodiline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  1988 Delphi survey of nursing research priorities for New York State.
Next Document:  Gastric bezoar after hepatic transplantation.